Ó Rolfsson1,2, Ó E Sigurjonsson3,4, M Magnusdottir1, F Johannsson1,2, G Paglia1,5, S Guðmundsson3, A Bordbar6, S Palsson6, S Brynjólfsson1, S Guðmundsson3, B Palsson1. 1. Center for Systems Biology, University of Iceland, Reykjavik, Iceland. 2. Medical Department, University of Iceland, Reykjavik, Iceland. 3. The Blood Bank, Landspitali-University Hospital, Reykjavik, Iceland. 4. School of Science and Engineering, Reykjavik University, Reykjavik, Iceland. 5. Center for Biomedicine, European Academy of Bolzano/Bozen, Bolzano, Italy. 6. Sinopia Bioscience, San Diego, CA, USA.
Abstract
BACKGROUND AND OBJECTIVES: Metabolomics studies have revealed transition points in metabolic signatures of red cells during storage in SAGM, whose clinical significance is unclear. We set out to investigate whether these transition points occur independent of storage media and define differences in the metabolism of red cells in additive solutions. MATERIALS AND METHODS: Red cell concentrates were stored in SAGM, AS-1, AS-3 or PAGGSM, and sampled fourteen times spanning Day 1-46. Following quality control, the samples were split into extracellular and intracellular aliquots. These were analysed with ultra-high-performance liquid chromatography coupled to mass spectrometry analysis affording quantitative metabolic profiles of both intra- and extracellular red cell metabolites. RESULTS: Differences were observed in glycolysis, purine salvage, glutathione synthesis and citrate metabolism on account of the storage solutions. Donor variability however hindered the accurate characterization of metabolic transition time-points. Intracellular citrate concentrations were increased in red cells stored in AS-3 and PAGGSM media. The metabolism of citrate in red cells in SAGM was subsequently confirmed using 13 C citrate isotope labelling and shown to originate from citrate anticoagulant. CONCLUSION: Metabolic signatures that discriminate between 'fresh' and 'old' stored red cells are dependent upon additive solutions. Specifically, the incorporation and metabolism of citrate in additive solutions with lower chloride ion concentration is altered and impacts glycolysis.
BACKGROUND AND OBJECTIVES: Metabolomics studies have revealed transition points in metabolic signatures of red cells during storage in SAGM, whose clinical significance is unclear. We set out to investigate whether these transition points occur independent of storage media and define differences in the metabolism of red cells in additive solutions. MATERIALS AND METHODS: Red cell concentrates were stored in SAGM, AS-1, AS-3 or PAGGSM, and sampled fourteen times spanning Day 1-46. Following quality control, the samples were split into extracellular and intracellular aliquots. These were analysed with ultra-high-performance liquid chromatography coupled to mass spectrometry analysis affording quantitative metabolic profiles of both intra- and extracellular red cell metabolites. RESULTS: Differences were observed in glycolysis, purine salvage, glutathione synthesis and citrate metabolism on account of the storage solutions. Donor variability however hindered the accurate characterization of metabolic transition time-points. Intracellular citrate concentrations were increased in red cells stored in AS-3 and PAGGSM media. The metabolism of citrate in red cells in SAGM was subsequently confirmed using 13 C citrate isotope labelling and shown to originate from citrate anticoagulant. CONCLUSION: Metabolic signatures that discriminate between 'fresh' and 'old' stored red cells are dependent upon additive solutions. Specifically, the incorporation and metabolism of citrate in additive solutions with lower chloride ion concentration is altered and impacts glycolysis.
Authors: Angelo D'Alessandro; Julie A Reisz; Rachel Culp-Hill; Herbert Korsten; Robin van Bruggen; Dirk de Korte Journal: Transfusion Date: 2018-04-06 Impact factor: 3.157
Authors: Davide Stefanoni; Xiaoyun Fu; Julie A Reisz; Tamir Kanias; Travis Nemkov; Grier P Page; Larry Dumont; Nareg Roubinian; Mars Stone; Steve Kleinman; Michael Busch; James C Zimring; Angelo D'Alessandro Journal: Transfusion Date: 2020-05-08 Impact factor: 3.157
Authors: Angelo D'Alessandro; Xiaoyun Fu; Julie A Reisz; Mars Stone; Steve Kleinman; James C Zimring; Michael Busch Journal: Transfusion Date: 2020-05-08 Impact factor: 3.157
Authors: Sarah Gehrke; Sarah Rice; Davide Stefanoni; Rebecca B Wilkerson; Travis Nemkov; Julie A Reisz; Kirk C Hansen; Alfredo Lucas; Pedro Cabrales; Kelly Drew; Angelo D'Alessandro Journal: J Proteome Res Date: 2019-02-28 Impact factor: 4.466
Authors: Angelo D'Alessandro; Rachel Culp-Hill; Julie A Reisz; Mikayla Anderson; Xiaoyun Fu; Travis Nemkov; Sarah Gehrke; Connie Zheng; Tamir Kanias; Yuelong Guo; Grier Page; Mark T Gladwin; Steve Kleinman; Marion Lanteri; Mars Stone; Michael Busch; James C Zimring Journal: Transfusion Date: 2018-10-24 Impact factor: 3.157
Authors: Angelo D'Alessandro; Xiaoyun Fu; Julie A Reisz; Tamir Kanias; Grier P Page; Mars Stone; Steve Kleinman; James C Zimring; Michael Busch Journal: Transfusion Date: 2020-05-11 Impact factor: 3.157